This is not the most recent version of the article. View current version (14 DEC 2015)

Intervention Protocol

You have free access to this content

Effects and safety of periconceptional folate supplementation for preventing birth defects

  1. Luz Maria De Regil1,*,
  2. Ana C Fernández-Gaxiola2,
  3. Therese Dowswell3,
  4. Juan Pablo Peña-Rosas4

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 8 JUL 2009

DOI: 10.1002/14651858.CD007950

How to Cite

De Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007950. DOI: 10.1002/14651858.CD007950.

Author Information

  1. 1

    Universidad Iberoamericana, Department of Health, Mexico City, Mexico

  2. 2

    Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico

  3. 3

    The University of Liverpool, Cochrane Pregnancy and Childbirth Group, School of Reproductive and Developmental Medicine, Division of Perinatal and Reproductive Medicine, Liverpool, UK

  4. 4

    World Health Organization, Reduction of Micronutrient Malnutrition Unit, Department of Nutrition for Health and Development, Geneva 27, Switzerland

*Luz Maria De Regil, Department of Health, Universidad Iberoamericana, Prol Paseo de la Reforma 880. Col. Lomas de Santa Fe, Mexico City, 01219, Mexico.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2009


This is not the most recent version of the article. View current version (14 DEC 2015)


Additional references

Berry 2005
  • Berry RJ, Kihlberg R, Devine O. Impact of misclassification of in vitro fertilization in studies of folic acid and twinning: modeling using population based Swedish vital records. BMJ 2005;330:815-8.
Berry 2009
  • Berry RJ. Report for FFI technical workshop on folic acid fortification of flour. CDC, 2009.
Botto 2006
Botto 2004
Botto 2005
  • Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?. BMJ 2005;330:571-3.
Busby 2006
  • Busby A,  Abramsky L, Dolk H, Armstrong B, Addor MC, Anneren G, et al. Preventing neural tube defects in Europe: a missed opportunity. Reproductive Toxicology 2006;20:393-402.
CDC 2008
  • Centers for Disease Control and Prevention. National Report on Biochemical Indicators of Diet and Nutrition in the US Population 1999-2002. Water soluble vitamins and related biochemical compounds. Atlanta, GA: Department of Health and Human Services, 2008.
Chango 2000
  • Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, et al. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Molecular Genetics and Metabolism 2000;70(4):310-5.
Cole 2007
Czeizel 1992
Czeizel 1994
  • Czeizel AE, Metneki J, Dudas I. The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae 1994;43(3-4):175-84.
Czeizel 2009
  • Czeizel AE. Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Research Part A. Clinical and Molecular Teratology 2009;85(4):260-8.
Deeks 2001
  • Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001.
English 2006
Ericson 2001
  • Ericson A, Kallen B, Aberg A. Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Research 2001;4(2):63-6.
Goh 2006
  • Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. Journal of Obstetrics and Gynaecology Canada: JOGC 2006;28:680-9.
Haider 2006
Haider 2008
  • Haider BA, Humayun Q, Bhutta ZA, Jabeen A. Folate supplementation in pregnancy. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006896]
Heseker 2008
  • Heseker HB, Mason JB, Selhub J, Rosenberg IH, Jacques PF. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. British Journal of Nutrition 2008 in press.
Higgins 2008
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from
Houghton 2006
  • Houghton LA, Sherwood KL, Pawlosky R, Ito S, O'Connor DL. [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. American Journal of Clinical Nutrition 2006;83(4):842-50.
IOM 2003
  • Bale JR, Stoll BJ, Lucas AO, editors. Reducing birth defects: meeting the challenge in the developing world. Washington: National Academies Press, 2003.
Iyengar 1975
Kucik 2004
  • Kucik J, Correa A. Trends in twinning rates in metropolitan Atlanta before and after folic acid fortification. Journal of Reproductive Medicine 2004;49(9):707-12.
Lamers 2004
  • Lamers Y, Prinz-Langenohl R, Moser R, Pietrzik K. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. American Journal of Clinical Nutrition 2004;79(3):473-8.
Li 2003
  • Li Z, Gindler J, Wang H, Berry RJ, Li S, Correa A, et al. Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. Lancet 2003;361(9355):380-4.
Life Sciences Research Office 1994
  • Life Sciences Research Office, Center for Food Safety and Applied Nutrition. Assessment of folate methodology used in the Third National Health and Nutrition Survey (NHANES 1988-1994). Washington DC: U.S. Food and Drug Administration, Department of Health and Human Services, 1994.
Lumley 2001
  • Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001056]
Makedos 2007
  • Makedos G, Papanicolaou A, Hitoglou A, Kalogiannidis I, Makedos A, Vrazioti V, et al. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia. Archives of Gynecology & Obstetrics 2007;275(2):121-4.
Mason 2007
  • Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiology, Biomarkers & Prevention 2007;16(7):1325-9.
McNulty 2004
Modell 1989
MRC 1991
  • Anonymous. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338(8760):131-7.
Murray 1997
Nduati 2008
  • Nduati E, Diriye A, Ommeh S, Mwai L, Kiara S, Masseno V, et al. Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer. Parasitology Research 2008;102(6):1227-34.
Patrick 2004
Peña Rosas 2006
Refsum 2008
Relton 2005
Reveiz 2007
RevMan 2008
  • The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
Rolschau 1999
  • Rolschau J, Kristoffersen K, Ulrich M, Grinsted P, Schaumburg E, Foged N. The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. European Journal of Obstetrics & Gynecology and Reproductive Biology 1999;87(2):105-10; discussion 103-4.
Selhub 2008
  • Selhub J, Jacques PF, Dallal G, Choumenkovitch S, Rogers G. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food & Nutrition Bulletin 2008;29(2 Suppl):S67-S73.
Shaw 2003
Shibuya 1998
  • Shibuya K, Murray C. Congenital anomalies. In: Murray C, Lopez A editor(s). Health dimensions of sex and reproduction. Boston: Harvard School of Public Health, 1998:463-73.
Signore 2005
Tamura 2006
Van der Put 1998
  • Van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. American Journal of Human Genetics 1998;62(5):1044-51.
Van Eijk 2008
  • Van Eijk AM, Ouma PO, Williamson J, Ter Kuile FO, Parise M, Otieno K, et al. Plasma folate level and high-dose folate supplementation predict sulfadoxine-pyrimethamine treatment failure in pregnant women in Western Kenya who have uncomplicated malaria. Journal of Infectious Diseases 2008;198(10):1550-3.
Venn 2002
  • Venn BJ, Green TJ, Moser R, McKenzie JE, Skeaff CM, Mann J. Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]-5-methyltetrahydrofolate and folic acid. Journal of Nutrition 2002;132(11):3353-5.
Venn 2003
  • Venn BJ, Green TJ, Moser R, Mann JI. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. American Journal of Clinical Nutrition 2003;77(3):658-62.
Vollset 2005
WHO 1997
  • Alwan AA, Modell B, editors. Community control of genetic and congenital disorders. Alexandria: WHO, 1997.
WHO 1999
  • World Health Organization. Human genetics: services for the prevention and management of genetic disorders and birth defects in developing countries. Report of a joint WHO/WOAPBD Meeting. Geneva: WHO, 1999.
WHO 2000
  • World Health Organization. Primary health care approaches for the prevention and control of congenital genetic disorders. Report of a WHO meeting. Geneva: WHO, 2000.
WHO 2004
  • Ahman E, Zupan J. Neonatal and perinatal mortality. Country, regional and global estimates 2004. Geneva: Department of Making Pregnancy Safer, WHO, 2004.
WHO 2006
  • World Health Organization. Prevention of neural tube defects. Standards for maternal and neonatal care. (accessed 22 January 2009).
WHO 2008
  • World Health Organization. Conclusions of a WHO technical consultation on folate and vitamin B12 deficiencies. Food and Nutrition Bulletin 2008;29(2 Suppl):S238-S244.
WHO 2009
  • World Health Organization. Weekly iron-folic acid supplementation (WIFS) in women of reproductive age: its role in promoting optimal maternal and child health. Position statement. (accessed 23 January 2009).
Wilcken 1997
Wilcox 2007
  • Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, et al. Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 2007;334(7591):464.
Yajnik 2008